Technical Analysis for BBLGW - Bone Biologics Corp - warrants
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| Multiple of Ten Bullish | Other | 0.00% | |
| BB Squeeze Ended | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 24.24% | |
| Narrow Range Bar | Range Contraction | 24.24% | |
| BB Squeeze Started | Range Contraction | 24.24% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 1 day ago |
| Rose Above Upper Bollinger Band | 1 day ago |
| Up 5% | 1 day ago |
| Up 3% | 1 day ago |
| Up 2% | 1 day ago |
Get a Trading Assistant
- Earnings date: Unknown
Bone Biologics Corp - warrants Description
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biopharmaceutical Neurosurgery Platform Technology Orthopedic Surgery Sports Medicine Surgical Specialties Spinal Fusion Degenerative Disc Disease Neurosurgical Procedures Spinal Fusion Applications
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 46.8 |
| 52 Week Low | 0.4334 |
| Average Volume | 1,280 |
| 200-Day Moving Average | 8.63 |
| 50-Day Moving Average | 19.60 |
| 20-Day Moving Average | 26.72 |
| 10-Day Moving Average | 30.99 |
| Average True Range | 3.60 |
| RSI (14) | 71.99 |
| ADX | 22.57 |
| +DI | 55.58 |
| -DI | 25.71 |
| Chandelier Exit (Long, 3 ATRs) | 35.99 |
| Chandelier Exit (Short, 3 ATRs) | 25.71 |
| Upper Bollinger Bands | 39.92 |
| Lower Bollinger Band | 13.53 |
| Percent B (%b) | 1.06 |
| BandWidth | 98.72 |
| MACD Line | 5.22 |
| MACD Signal Line | 3.91 |
| MACD Histogram | 1.3171 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 51.97 | ||||
| Resistance 3 (R3) | 50.82 | 46.22 | 50.25 | ||
| Resistance 2 (R2) | 46.22 | 43.58 | 46.80 | 49.67 | |
| Resistance 1 (R1) | 43.92 | 41.96 | 45.07 | 45.07 | 49.09 |
| Pivot Point | 39.32 | 39.32 | 39.90 | 39.90 | 39.32 |
| Support 1 (S1) | 37.02 | 36.68 | 38.17 | 38.17 | 34.15 |
| Support 2 (S2) | 32.42 | 35.06 | 33.00 | 33.57 | |
| Support 3 (S3) | 30.12 | 32.42 | 33.00 | ||
| Support 4 (S4) | 31.27 |
